Coronavirus

2019-20 coronavirus outbreak

Virology

Clinical trial

Archaeology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Outbreak

Coronavirus disease 2019 (COVID-19)

Political science

Interim

Infectious disease (medical specialty)

Interim analysis

Internal medicine

Medicine

Pandemic

Disease

History

New England Journal of Medicine

Efficacious vaccines are urgently needed to contain the ongoing coronavirus disease 2019 (Covid-19) pandemic of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A candidate vaccine, Ad26.COV2.S, is a recombinant, replication-incompetent adenovirus serotype 26 (Ad26) vector encoding a full-length and stabilized SARS-CoV-2 spike protein.

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine